companydata.dkBIODANE PHARMA A/S: Financial statements 2020
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,628,847 and a net result of DKK 499,535 compared with DKK 256,752 the year before. That is an increase of 8% compared with the year before. Equity amounted to DKK 2,158,515. The solvency ratio was 89%. The company had 1 employee in the financial year.
- Gross Profit
- 1,628,847 kr.
- Profit/Loss
- 499,535 kr.
- Equity
- 2,158,515 kr.
- Total Assets
- 2,426,633 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.6 mio. | 500 t. | 2.2 mio. | 1 |
| 2019 | - | 1.5 mio. | 257 t. | 1.7 mio. | 1 |
| 2018 | - | 1 mio. | -467 t. | 1.4 mio. | 1 |
| 2017 | - | 968 t. | 103 t. | 1.9 mio. | 1 |
| 2016 | - | 747 t. | 33 t. | 767 t. | 1 |
How creditworthy is BIODANE PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BIODANE PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 1,508,453, and the net result was DKK 256,752.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.